ScholarLens Back to search
2005•Journal of Thoracic and Cardiovascular SurgeryOpen access

Dimethyl celecoxib as a novel non–cyclooxygenase 2 therapy in the treatment of non–small cell lung cancer

Leah M. Backhus, Nicos A. Petasis, Jasim Uddin, Axel H. Schönthal, Robert D. Bart, Yuanguang Lin, Vaughn A. Starnes, Ross M. Bremner

Open full text 27 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 27 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Celecoxib, Cyclooxygenase, Medicine, Prostaglandin E2, Pharmacology, Apoptosis, Prostaglandin, Viability assay

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Dimethyl celecoxib as a novel non–cyclooxygenase 2 therapy in the treatment of non–small cell lung cancer — Research Paper | ScholarLens